Axogen, Inc. — Director's Dealing 2025

Mar 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-03-03

Reporting Person: Wendell Amy McBride (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-03	Common Stock	S	5000	$20.02	Disposed	97899	Direct

Footnotes

F1: The reported shares were sold pursuant to an Approved Rule 10b5-1 Plan, as defined under the Company's Insider Trading Policy.

F2: The reported price in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.